Clinical Trials Browser

Phase 2/3 × Active not recruiting × pembrolizumab × Clear all

NCT06984588 2026-01-30

A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06295809 2025-12-09

INTerpath-007

Phase 2/3 Active not recruiting

Carcinoma, Squamous Cell, Skin Neoplasms

NCT06082167 2025-08-17

STELLAR-305

Phase 2/3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05096663 2025-05-15

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms